Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/cyto.a.24309 http://scihub22266oqcxt.onion/10.1002/cyto.a.24309 33522107!8014675!33522107     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cytometry+A 2021 ; 99 (5): 429-434 Nephropedia Template TP {{tp|p=33522107|t=2021. Sustained cellular immunity in adults recovered from mild COVID-19 |pdf=|usr=}}{{33522107}} gab.com Text Sustained cellular immunity in adults recovered from mild COVID-19 JO: Cytometry A http://www.kidney.de/pget.php?&tw=1&pmid=33522107 #FOAvip Transient lymphocytopenia is frequently observed in acute phase of coronavirus disease 2019 (COVID-19). It remains a concern whether impairment of cellular immunity may be retained after COVID-19. Here, we demonstrate by extensive lymphocyte profiling in 44 adults after mild COVID-19 that cellular immunity is not fundamentally altered in convalescent patients. Except for increased activated CD8+ lymphocytes, total counts of B, T, and NK cells and their subsets did not differ significantly between patients after COVID-19 and healthy controls after a median of 27 days (range 13-45) suggesting no residual cellular immune deficiency after recovery from mild COVID-19. Twit Text FOAVip Sustained cellular immunity in adults recovered from mild COVID-19 ????Cytometry A http://www.kidney.de/pget.php?&tw=1&pmid=33522107 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33522107 #FOAvip English Wikipedia <ref>{{Cite pmid|33522107}}</ref> Sustained cellular immunity in adults recovered from mild COVID-19 #MMPMID33522107 Rank A; Lohr P; Hoffmann R; Ebigbo A; Grutzner S; Schmid C; Claus R Cytometry A 2021[May]; 99 (5): 429-434 PMID33522107show ga Transient lymphocytopenia is frequently observed in acute phase of coronavirus disease 2019 (COVID-19). It remains a concern whether impairment of cellular immunity may be retained after COVID-19. Here, we demonstrate by extensive lymphocyte profiling in 44 adults after mild COVID-19 that cellular immunity is not fundamentally altered in convalescent patients. Except for increased activated CD8+ lymphocytes, total counts of B, T, and NK cells and their subsets did not differ significantly between patients after COVID-19 and healthy controls after a median of 27 days (range 13-45) suggesting no residual cellular immune deficiency after recovery from mild COVID-19. |*Immunity, Cellular[MESH] |Adolescent[MESH] |Adult[MESH] |COVID-19/diagnosis/*immunology/virology[MESH] |Female[MESH] |Host-Pathogen Interactions[MESH] |Humans[MESH] |Lymphocyte Count[MESH] |Lymphocytes/*immunology/virology[MESH] |Male[MESH] |Middle Aged[MESH] |Phenotype[MESH] |Retrospective Studies[MESH] |SARS-CoV-2/*immunology/pathogenicity[MESH] |Time Factors[MESH]Sustained cellular immunity in adults recovered from mild COVID-19 (epmc).pdf DeepDyve Pubget Overpricing